Skip to Content
Merck
CN
  • Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature.

Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature.

American journal of clinical dermatology (2011-08-13)
Matteo Auriemma, Angelo Carbone, Lorenzo Di Liberato, Antonietta Cupaiolo, Chiara Caponio, Clara De Simone, Antonio Tulli, Mario Bonomini, Paolo Amerio
ABSTRACT

Cutaneous calciphylaxis is a potentially fatal condition characterized by calcium deposition in dermal arterioles and the subsequent development of livedo reticularis, plaques, and extremely painful ulcers. This condition may be present in up to 4% of end-stage renal disease patients. Several treatments, which mainly attempt to control calcium phosphate metabolism, are available for this condition. We describe two patients treated with sodium thiosulfate with good results. Moreover, we also performed a PubMed literature search of sodium thiosulfate treatment for calciphylaxis. We found 41 cases of which most (> 90%) presented a rapid and sustained resolution, indicating this drug is a very good candidate for the treatment of this condition.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium thiosulfate, purum p.a., anhydrous, ≥98.0% (RT)
Sigma-Aldrich
Sodium thiosulfate, ReagentPlus®, 99%
Sigma-Aldrich
Sodium thiosulfate, ≥99.99% trace metals basis